Helicobacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000
Surveillance of Helicobacter pylori antibiotic susceptibility from patients in London, the largest metropolitan area in the UK, is limited, despite resistance being a key factor in treatment failure. A two-centre survey was performed over 12 months (1999–2000) to determine antibiotic-resistance rates of isolates from dyspeptic patients attending endoscopy clinics serving two ethnically diverse central and south London communities. The in vitro antibiotic susceptibilities were determined from disc diffusion and epsilometer (E) tests on 101 H. pylori isolates. Overall resistance rates were 59 % for metronidazole and 11 % for clarithromycin, with 8 % resistance to both antibiotics. Corresponding primary resistance rates were 50 % and 7 %, respectively. High-level-resistance was a feature of 82 % of the metronidazole (MIC ⩾ 256 mg l−1) -resistant and 55 % of the clarithromycin (MIC ⩾ 32 mg l−1) -resistant strains. All isolates were susceptible to amoxycillin and tetracycline. No associations between resistance and either the gender or the age of the patients were detected. The main risk for resistance to metronidazole was non-UK birth as comparative rates were 68 % for non-UK vs. 40 % for UK-born individuals. Resistant isolates were genotypically diverse with respect to cagA/vacA type. Four 23S rDNA nucleotide polymorphisms were associated with clarithromycin resistance, mostly (9/11) at A2143G. In conclusion, the high overall metronidazole-resistance rate of 59 % for H. pylori from inner London was twice the rate found in other UK-based studies and was attributed to the higher risk of resistant strains infecting individuals born outside the UK. The need for continued resistance surveillance is indicated to monitor the effects of the ‘test and treat’ strategy for H. pylori eradication, particularly of isolates from at-risk individuals
AndrewsJ.2003BSAC Disc Diffusion Method for Antimicrobial Susceptibility Testing , Version 2.1.4 Birmingham, UK: British Society for Antimicrobial Chemotherapy;
BanatvalaN.,
DaviesG. R.,
AbdiY.,
ClementsL.,
RamptonD. S.,
HardieJ. M.,
FeldmanR. A.1994; High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 35:1562–1566[CrossRef]
CameronE. A. B.,
PowellK. U.,
BaldwinL.,
JonesP.,
BellG. D.,
WilliamsS. G. J.2004; Helicobacter pylori : antibiotic resistance and eradication rates in Suffolk, UK, 1991–2001. J Med Microbiol 53:535–538[CrossRef]
ChisholmS. A.,
OwenR. J.2003; Mutations in Helicobacter pylori rdxA gene sequences may not contribute to metronidazole resistance. J Antimicrob Chemother 51:995–999[CrossRef]
DoreM. P.,
LeandroG.,
RealdiG.,
SepulvedaA. R.,
GrahamD. Y.2000; Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci 45:68–76[CrossRef]
DuckW. M.,
SobelJ.,
PrucklerJ. M. & 21 other authors; 2004; Antimicrobial resistance incidence and risk factors among Helicobacter pylori -infected persons, United States. Emerg Infect Dis 10:1088–1094[CrossRef]
ElvissN. C.,
OwenR. J.,
XerryJ.,
WalkerM.,
DaviesK.2004a; Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J Antimicrob Chemother 54:435–440[CrossRef]
ElvissN. C.,
LawsonA. J.,
OwenR. J.2004b; Application of 3′-mismatched reverse primer PCR compared with real-time PCR and PCR-RFLP for the rapid detection of 23S rDNA mutations associated with clarithromycin resistance in Helicobacter pylori
. Int J Antimicrob Agents 23:349–355[CrossRef]
GlupczynskiY.,
BroutetN.,
CantagrelA.,
AndersenL. P.,
AlarcónT.,
López-BreaM.,
MégraudF.2002; Comparison of the E Test and agar dilution method for antimicrobial susceptibility testing of Helicobacter pylori
. Eur J Clin Microbiol Infect Dis 21:549–552[CrossRef]
KistM.,
GlockerE.2004; ResiNet – a nationwide German sentinel study for surveillance and analysis of antimicrobial resistance in Helicobacter pylori
. Eurosurveillance 9:44–45
MeyerJ. M.,
SillimanN. P.,
WangW. & 7 other authors; 2002; Risk factors for Helicobacter pylori resistance in the United States: the Surveillance of H.pylori Antimicrobial Resistance Partnership (SHARP) study, 1993–1999. Ann Intern Med 136:13–24[CrossRef]
NCCLS1999Performance Standards for Antimicrobial Susceptibility Testing. Approved Standard M7-A5: Informational Supplement M100-S10. Wayne, PA: National Committee for Clinical Laboratory Standards;
NICE2003; Dyspepsia: Managing Adult Patients in Primary Care , 2nd draft. London: National Guideline Research and Development Unit; www.nice.org.uk (accessed 23 August 2004)
OwenR. J.2002; Molecular testing for antibiotic resistance in Helicobacter pylori
. Gut 50:285–289[CrossRef]
OwenR. J.,
XerryJ.,
PetersT. M.,
TeareE. L.2002; Surveillance and clinical relevance of vacA genotypes of Helicobacter pylori infecting dyspeptic patients in mid-Essex. Commun Dis Public Health 5:106–111
ParsonsH. K.,
CarterM. J.,
SandersD. S.,
WinstanleyT.,
LoboA. J.2001; Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status. Aliment Pharmacol Ther 15:1473–1478[CrossRef]
ThyagarajanS. P.,
RayP.,
DasB. K. & 10 other authors; 2003; Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicentric study. J Gastroenterol Hepatol 18:1373–1378[CrossRef]
VyseA. J.,
GayN. J.,
HeskethL. M.,
AndrewsN. J.,
MarshallB.,
ThomasH. I.,
Morgan-CapnerP.,
MillerE.2002; The burden of Helicobacter pylori infection in England and Wales. Epidemiol Infect 128:411–417
WolleK.,
LeodolterA.,
MalfertheinerP.,
KonigW.2002; Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol 51:705–709
Helicobacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000